Line probe assay test in new cases of tuberculosis with rifampicin resistance not detected by Xpert MTB/RIF.

Soedarsono, Soedarsono; Mertaniasih, Ni Made; Hasan, Helmia; Kusmiati, Tutik; Permatasari, Ariani; Kusumaningrum, Deby; Wijaksono, Whendy

Soedarsono, Soedarsono; Mertaniasih, Ni Made; Hasan, Helmia; Kusmiati, Tutik; Permatasari, Ariani; Kusumaningrum, Deby; Wijaksono, Whendy.

Afiliação

Soedarsono S; Department of Pulmonology and Respiratory Medicine, Airlangga University; Sub-Pulmonology Department of Internal Medicine, Faculty of Medicine, Hang Tuah University, Surabaya, Indonesia.
Mertaniasih NM; Department of Clinical Microbiology, Faculty of Medicine; Tuberculosis Study Group, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Hasan H; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.
Kusmiati T; Department of Pulmonology and Respiratory Medicine; Tuberculosis Study Group, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Permatasari A; Department of Pulmonology and Respiratory Medicine; Tuberculosis Study Group, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Kusumaningrum D; Department of Clinical Microbiology, Faculty of Medicine; Tuberculosis Study Group, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Wijaksono W; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.

Int J Mycobacteriol ; 11(4): 429-434, 2022.

Article em En | MEDLINE | ID: mdl-36510930

Assuntos

Mycobacterium tuberculosis; Tuberculose Resistente a Múltiplos Medicamentos; Tuberculose; Humanos; Farmacorresistência Bacteriana; Testes de Sensibilidade Microbiana; Mycobacterium tuberculosis/genética; Rifampina/farmacologia; Rifampina/uso terapêutico; Sensibilidade e Especificidade; Escarro; Tuberculose/tratamento farmacológico; Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico; Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico

Palavras-chave

Culture-based drug susceptibility test; Xpert MTB/RIF; drug-resistant tuberculosis; first-line line probe assay; isoniazid-resistant tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies Limite: Humans Idioma: En Revista: Int J Mycobacteriol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Indonésia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google